Valuation : Proteome Sciences plc

Market Cap 4.91M 6.65M 5.72M 5.39M 9.19M 633M 9.22M 63.87M 24.68M 322M 24.97M 24.43M 1.02B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.9M 26.95M 23.19M 21.84M 37.23M 2.56B 37.38M 259M 100M 1.31B 101M 99.01M 4.14B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
Current month-9.68%
1 month-22.22%
3 months-21.13%
6 months-20.00%
Current year-44.00%
1 week 1.21
Extreme 1.21
1.6
1 month 1.21
Extreme 1.21
2.1
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
7.5
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
13.75
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap. Importance
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
6/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-58.46%-77.60% 6.65M
-0.27%-4.74%-20.25%+4.47% 183B
-0.54%-0.31%-2.32%+14.92% 118B
-0.42%-3.88%+8.25%+81.95% 61.96B
-1.27%-6.23%+10.69%+42.63% 50.6B
+0.98%-4.12%-5.61%-32.60% 48.78B
-0.77%-6.48%+6.99%-19.62% 31.9B
-1.84%-6.20% - - 30.44B
-0.24%-1.66%+33.69%-14.30% 23.77B
-2.91%-10.72%-14.94%+2.85% 22.26B
Average -0.72%-3.80%-4.66%+0.30% 57.05B
Weighted average by Cap. -0.53%-3.14%-4.63%+13.56%

Financials

2024 2025
Net sales 4.89M 6.62M 5.7M 5.36M 9.14M 630M 9.18M 63.57M 24.57M 321M 24.86M 24.32M 1.02B 3.76M 5.09M 4.38M 4.12M 7.03M 484M 7.06M 48.86M 18.88M 247M 19.1M 18.69M 781M
Net income -3.41M -4.61M -3.97M -3.74M -6.37M -439M -6.4M -44.3M -17.12M -224M -17.32M -16.95M -709M -3.06M -4.15M -3.57M -3.36M -5.73M -395M -5.75M -39.82M -15.39M -201M -15.57M -15.23M -637M
Net Debt 13.39M 18.14M 15.61M 14.7M 25.06M 1.73B 25.16M 174M 67.33M 880M 68.13M 66.65M 2.79B 14.99M 20.3M 17.47M 16.45M 28.04M 1.93B 28.16M 195M 75.35M 984M 76.24M 74.58M 3.12B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
09/09/26 GBX 1.400 0.00% 232
08/09/26 GBX 1.400 0.00% 2,633
07/09/26 GBX 1.400 0.00% 4,629
04/09/26 GBX 1.400 -3.45% 4,662
03/09/26 GBX 1.450 +3.57% 392,957
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!